Sesen Bio, Inc. is a clinical company that specializes in creating fusion protein therapeutics to treat different types of cancer. Its notable products include Vicineum which is in Phase III clinical trials for bladder cancer, and VB6-845d to treat various types of solid tumors. Sesen Bio, Inc. recently partnered with Leiden University Medical Center to develop an imaging agent.